Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
February 1, 2021
Assessment of Radiation Oncology Nurse Education in the United States
Marina Moskalenko, Jennifer Zaccone, Cheryl A Fiscelli, et al.
Diseases of the Colon and Rectum
|
January 5, 2022
Rectal Cancer: Clinical and Molecular Predictors of a Complete Response to Total Neoadjuvant Therapy
Brandon C Chapman, Samuel H Lai, Tyler Friedrich, et al.
Nature Biotechnology
|
December 26, 2001
Production of human clotting Factor IX without toxicity in mice after vascular delivery of a lentiviral vector
Lisa V Tsui, Michael Kelly, Nathalie Zayek, et al.
Immunity
|
March 6, 2016
MAP Kinase Inhibition Promotes T Cell and Anti-tumor Activity in Combination with PD-L1 Checkpoint Blockade
Peter J R Ebert, Jeanne Cheung, Yagai Yang, et al.
Journal of Neurosurgery. Pediatrics
|
September 27, 2024
Does pre-irradiation gross tumor volume predict the risk of progression after radiation therapy in pediatric patients with adamantinomatous craniopharyngioma?
Tamar Brooks, Dexiang Gao, Kathleen Dorris, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
February 9, 2023
Total Neoadjuvant Therapy in Rectal Cancer: Multi-center Comparison of Induction Chemotherapy and Long-Course Chemoradiation Versus Short-Course Radiation and Consolidative Chemotherapy
Amber M Moyer, Jon D Vogel, Samuel H Lai, et al.
Cancer Immunology Research
|
January 21, 2015
Requirement for innate immunity and CD90⁺ NK1.1⁻ lymphocytes to treat established melanoma with chemo-immunotherapy
Marina Moskalenko, Michael Pan, Yichun Fu, et al.
Journal of the American Academy of Dermatology
|
April 5, 2014
Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage-II to -III cutaneous melanoma
Sara Harcharik, Sebastian Bernardo, Marina Moskalenko, et al.
Cancer Immunology Research
|
May 9, 2019
Coexpression of Inhibitory Receptors Enriches for Activated and Functional CD8<sup>+</sup> T Cells in Murine Syngeneic Tumor Models
Huizhong Xiong, Stephanie Mittman, Ryan Rodriguez, et al.
Cancer Immunology, Immunotherapy : CII
|
June 17, 2015
Immune biomarkers are more accurate in prediction of survival in ulcerated than in non-ulcerated primary melanomas
Ellen H de Moll, Yichun Fu, Yingzhi Qian, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
International Journal of Radiation Oncology, Biology, Physics
|
February 1, 2021
Assessment of Radiation Oncology Nurse Education in the United States
Marina Moskalenko, Jennifer Zaccone, Cheryl A Fiscelli, et al.
Diseases of the Colon and Rectum
|
January 5, 2022
Rectal Cancer: Clinical and Molecular Predictors of a Complete Response to Total Neoadjuvant Therapy
Brandon C Chapman, Samuel H Lai, Tyler Friedrich, et al.
Nature Biotechnology
|
December 26, 2001
Production of human clotting Factor IX without toxicity in mice after vascular delivery of a lentiviral vector
Lisa V Tsui, Michael Kelly, Nathalie Zayek, et al.
Immunity
|
March 6, 2016
MAP Kinase Inhibition Promotes T Cell and Anti-tumor Activity in Combination with PD-L1 Checkpoint Blockade
Peter J R Ebert, Jeanne Cheung, Yagai Yang, et al.
Journal of Neurosurgery. Pediatrics
|
September 27, 2024
Does pre-irradiation gross tumor volume predict the risk of progression after radiation therapy in pediatric patients with adamantinomatous craniopharyngioma?
Tamar Brooks, Dexiang Gao, Kathleen Dorris, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
February 9, 2023
Total Neoadjuvant Therapy in Rectal Cancer: Multi-center Comparison of Induction Chemotherapy and Long-Course Chemoradiation Versus Short-Course Radiation and Consolidative Chemotherapy
Amber M Moyer, Jon D Vogel, Samuel H Lai, et al.
Cancer Immunology Research
|
January 21, 2015
Requirement for innate immunity and CD90⁺ NK1.1⁻ lymphocytes to treat established melanoma with chemo-immunotherapy
Marina Moskalenko, Michael Pan, Yichun Fu, et al.
Journal of the American Academy of Dermatology
|
April 5, 2014
Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage-II to -III cutaneous melanoma
Sara Harcharik, Sebastian Bernardo, Marina Moskalenko, et al.
Cancer Immunology Research
|
May 9, 2019
Coexpression of Inhibitory Receptors Enriches for Activated and Functional CD8<sup>+</sup> T Cells in Murine Syngeneic Tumor Models
Huizhong Xiong, Stephanie Mittman, Ryan Rodriguez, et al.
Cancer Immunology, Immunotherapy : CII
|
June 17, 2015
Immune biomarkers are more accurate in prediction of survival in ulcerated than in non-ulcerated primary melanomas
Ellen H de Moll, Yichun Fu, Yingzhi Qian, et al.
Page
of 4